MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshizumi, M.
Right arrow Articles by Tamaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshizumi, M.
Right arrow Articles by Tamaki, T.

Vol. 60, Issue 4, 656-665, October 2001

Quercetin Inhibits Shc- and Phosphatidylinositol 3-Kinase-Mediated c-Jun N-Terminal Kinase Activation by Angiotensin II in Cultured Rat Aortic Smooth Muscle Cells

Masanori Yoshizumi, Koichiro Tsuchiya, Kazuyoshi Kirima, Moe Kyaw, Yuki Suzaki, and Toshiaki Tamaki

Department of Pharmacology, The University of Tokushima School of Medicine, Tokushima, Japan

Angiotensin II (Ang II) induces vascular smooth muscle cell (VSMC) hypertrophy, which results in various cardiovascular diseases. Ang II-induced cellular events have been implicated, in part, in the activation of mitogen-activated protein (MAP) kinases. Although it has been proposed that daily intake of bioflavonoids belonging to polyphenols reduces the incidence of ischemic heart diseases (known as "French paradox"), the precise mechanisms of efficacy have not been elucidated. Thus, we hypothesized that bioflavonoids may affect Ang II-induced MAP kinase activation in cultured rat aortic smooth muscle cells (RASMC). Our findings showed that Ang II stimulated rapid and significant activation of extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK), and p38 in RASMC. Ang II-induced JNK activation was inhibited by 3,3',4',5,7-pentahydroxyflavone (quercetin), a major bioflavonoid in foods of plant origin, whereas ERK1/2 and p38 activation by Ang II were not affected by quercetin. Ang II caused a rapid tyrosine phosphorylation of Src homology and collagen (Shc), which was inhibited by quercetin. Quercetin also inhibited Ang II-induced Shc·p85 association and subsequent activation of phosphatidylinositol 3-kinase (PI3-K)/Akt pathway in RASMC. Furthermore, LY294002, a PI3-K inhibitor and a quercetin derivative, inhibited Ang II-induced JNK activation as well as Akt phosphorylation. Finally, Ang II-induced [3H]leucine incorporation was abolished by both quercetin and LY294002. These findings suggest that the preventing effect of quercetin on Ang II-induced VSMC hypertrophy are attributable, in part, to its inhibitory effect on Shc- and PI3-K-dependent JNK activation in VSMC. Thus, inhibition of JNK by quercetin may imply its usefulness for the treatment of cardiovascular diseases relevant to VSMC growth.

Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Cancer Res.Home page
Q.-S. Zhu, W. Ren, B. Korchin, G. Lahat, A. Dicker, Y. Lu, G. Mills, R. E. Pollock, and D. Lev
Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45{alpha}
Cancer Res., April 15, 2008; 68(8): 2895 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. B. Granado-Serrano, M. A. Martin, L. Bravo, L. Goya, and S. Ramos
Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2)
J. Nutr., November 1, 2006; 136(11): 2715 - 2721.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Fujita, M. Yoshizumi, Y. Izawa, N. Ali, H. Ohnishi, Y. Kanematsu, K. Ishizawa, K. Tsuchiya, and T. Tamaki
Transactivation of Fetal Liver Kinase-1/Kinase-Insert Domain-Containing Receptor by Lysophosphatidylcholine Induces Vascular Endothelial Cell Proliferation
Endocrinology, March 1, 2006; 147(3): 1377 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Graiani, C. Lagrasta, E. Migliaccio, F. Spillmann, M. Meloni, P. Madeddu, F. Quaini, I. M. Padura, L. Lanfrancone, P. Pelicci, et al.
Genetic Deletion of the p66Shc Adaptor Protein Protects From Angiotensin II-Induced Myocardial Damage
Hypertension, August 1, 2005; 46(2): 433 - 440.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P.-C. Kuo, H.-F. Liu, and J.-I Chao
Survivin and p53 Modulate Quercetin-induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinoma Cells
J. Biol. Chem., December 31, 2004; 279(53): 55875 - 55885.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
P. Zahradka, B. Litchie, B. Storie, and G. Helwer
Transactivation of the Insulin-Like Growth Factor-I Receptor by Angiotensin II Mediates Downstream Signaling from the Angiotensin II Type 1 Receptor to Phosphatidylinositol 3-Kinase
Endocrinology, June 1, 2004; 145(6): 2978 - 2987.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T.T.T. Nguyen, E. Tran, T.H. Nguyen, P.T. Do, T.H. Huynh, and H. Huynh
The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells
Carcinogenesis, May 1, 2004; 25(5): 647 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Natarajan, G. Yin, and B. C. Berk
Scaffolds Direct Src-Specific Signaling in Response to Angiotensin II: New Roles for Cas and GIT1
Mol. Pharmacol., April 1, 2004; 65(4): 822 - 825.
[Full Text]

Home page
 Mol. Pharmacol.Home page
M. Kyaw, M. Yoshizumi, K. Tsuchiya, S. Kagami, Y. Izawa, Y. Fujita, N. Ali, Y. Kanematsu, K. Toida, K. Ishimura, et al.
Src and Cas Are Essentially but Differentially Involved in Angiotensin II-Stimulated Migration of Vascular Smooth Muscle Cells via Extracellular Signal-Regulated Kinase 1/2 and c-Jun NH2-Terminal Kinase Activation
Mol. Pharmacol., April 1, 2004; 65(4): 832 - 841.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
P. G. Arndt, N. Suzuki, N. J. Avdi, K. C. Malcolm, and G. S. Worthen
Lipopolysaccharide-induced c-Jun NH2-terminal Kinase Activation in Human Neutrophils: ROLE OF PHOSPHATIDYLINOSITOL 3-KINASE AND Syk-MEDIATED PATHWAYS
J. Biol. Chem., March 19, 2004; 279(12): 10883 - 10891.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
J. W. Burgess, J. Boucher, T. A-M. Neville, P. Rouillard, C. Stamler, S. Zachariah, and D. L. Sparks
Phosphatidylinositol promotes cholesterol transport and excretion
J. Lipid Res., July 1, 2003; 44(7): 1355 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Dugourd, M. Gervais, P. Corvol, and C. Monnot
Akt Is a Major Downstream Target of PI3-Kinase Involved in Angiotensin II-Induced Proliferation
Hypertension, April 1, 2003; 41(4): 882 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
U. G. B. Haider, D. Sorescu, K. K. Griendling, A. M. Vollmar, and V. M. Dirsch
Resveratrol Suppresses Angiotensin II-Induced Akt/Protein Kinase B and p70 S6 Kinase Phosphorylation and Subsequent Hypertrophy in Rat Aortic Smooth Muscle Cells
Mol. Pharmacol., October 1, 2002; 62(4): 772 - 777.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics